FrozenShoulderCentral Sensitization Impact on Shoulder Adhesive Capsulitis Treatment
Data Collection
Collected from today forward - ProspectiveBursitis+5
+ Joint Diseases
+ Musculoskeletal Diseases
Case-Control
Comparing exposures between individuals with and without disease in order to identify potential risk factors.Summary
Study start date: January 1, 2021
Actual date on which the first participant was enrolled.Adhesive capsulitis, commonly known as frozen shoulder, causes chronic shoulder pain and affects daily activities. This study focuses on understanding how a condition called central sensitization, which amplifies pain signals in the central nervous system, influences the effectiveness of treatments for adhesive capsulitis. Central sensitization can make treatment challenging and reduce its success. The study includes 32 participants who have adhesive capsulitis, some of whom also have central sensitization. The aim is to determine if the presence of central sensitization affects the outcomes of physical therapy and exercise treatments. Understanding this relationship could improve treatment strategies and provide better relief for those suffering from prolonged shoulder pain. Participants receive conventional physical therapy and exercise treatments. Their progress is measured using several scales: the Visual Analog Scale (VAS) to assess pain severity, the Shoulder Pain and Disability Index (SPADI) to evaluate shoulder pain and disability, and the Tampa Kinesiophobia Scale (TKS) and Pain Catastrophizing Scale (PCS) to consider psychological factors related to pain. Additionally, shoulder range of motion is measured at three different times: before treatment, immediately after treatment, and two weeks post-treatment. These measurements help determine the effectiveness of the treatments and whether central sensitization affects recovery. The study could identify specific needs for those with central sensitization, leading to more tailored treatment approaches.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.32 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Case-Control
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 18 to 80 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Inclusion Criteria: 1)patients with adhesive capsulitis between 18-80 years old 2) symptoms ongoing more than 3 months 3) willing to participated in the study Exclusion Criteria: 1\) patients with cervical radiculopathy 2) Patients with predisposing factors to adhesive capsulitis, such as diabetes mellitus, thyroid disease, coronary artery disease, lung pathologies or tuberculosis 3) any defined central sensitization syndrome such as fibromiyalgia before 4) presence of rheumatologic diseases 5) pregnancy 6) patients underwent bypass surgery or who have cardiac pacemaker 7) patients with septic arthritis or sepsis 8) malignancy 9) patients that underwent surgery through the shoulder region or had injection through the shoulder joint in the last 3 months. \-
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Study Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
Ankara Bilkent City Hospital
Ankara, Turkey (Türkiye)Open Ankara Bilkent City Hospital in Google Maps